Research Article | Open Access
Concurrent Beet Juice and Carbohydrate Ingestion: Influence on Glucose Tolerance in Obese and Nonobese Adults
Insulin resistance and obesity are characterized by low nitric oxide (NO) bioavailability. Insulin sensitivity is improved with stimulation of NO generating pathways. Consumption of dietary nitrate () increases NO formation, via reduction to nitrite () by oral bacteria. We hypothesized that acute dietary nitrate (beet juice) ingestion improves insulin sensitivity in obese but not in nonobese adults. 12 nonobese (body mass index: kg/m2 (mean ± SE)) and 10 obese adults ( kg/m2) ingested beet juice, supplemented with 25 g of glucose (carbohydrate load: 75 g), with and without prior use of antibacterial mouthwash to inhibit reduction to . Blood glucose concentrations after beet juice and glucose ingestion were greater in obese compared with nonobese adults at 60 and 90 minutes (). Insulin sensitivity, as represented by the Matsuda Index (where higher values reflect greater insulin sensitivity), was lower in obese compared with nonobese adults (). Antibacterial mouthwash rinsing decreased insulin sensitivity in obese ( versus ) but not in nonobese ( versus ) adults (). In conclusion, insulin sensitivity was improved in obese but not in nonobese adults following coingestion of beet juice and glucose when oral bacteria nitrate reduction was not inhibited. Obese adults may benefit from ingestion of healthy nitrate-rich foods during meals.
Insulin resistance and obesity, two common comorbidities, are both characterized by low nitric oxide (NO) bioavailability [1–3]. It is likely that this low NO bioavailability contributes directly to insulin resistance [2, 4], potentially via disrupted lipid handling, increased fat mass, and/or decreased glucose delivery [1, 4, 5]. For example, compared with healthy wild-type mice, mice lacking the gene for endothelial nitric oxide synthase (eNOS) develop insulin resistance and hypertension . In rats, disruption of NO generation via nitric oxide synthase inhibition attenuates insulin mediated glucose uptake . In humans, the D298 and IVS18 + 27 C alleles of the eNOS gene are more frequently observed in adults with type 2 diabetes compared with healthy controls [8, 9]. In light of these observations, increasing NO bioavailability may be an effective strategy to increase insulin sensitivity . In this regard, ingestion of dietary nitrate may hold promise.
During the previous decade, the remarkable effects of dietary nitrate, as beet (root) juice, have been described; these effects include decreased oxygen cost of standardized physical activity , increased exercise performance and fatigue resistance [11, 12], and improved regulation of blood flow [13, 14]. Considerably less attention has been given to the potential influence of dietary nitrate supplementation on insulin resistance and metabolic syndrome. In rodent models of obesity/diabetes, dietary nitrate supplementation improved insulin signaling and promoted glucose transporter 4 translocation [15, 16]. Further, in eNOS-deficient mice, 10 weeks of dietary nitrate supplementation normalized blood glucose tolerance and glycosylated hemoglobin . Compared with animal studies, data from human studies are sparse and do not consistently demonstrate a favorable benefit of dietary nitrate as it pertains to glucose control [18–23]. Potential reasons for these inconsistent and/or negative outcomes include issues pertaining to nitrate dosing and the short half-lives of NO and circulating nitrate/nitrite following ingestion.
The purpose of the study described herein was to determine the influence of coingestion of dietary nitrate (beet juice: BJ) with glucose on glucose tolerance in obese adults, a population with presumably low NO bioavailability [1, 3, 24], and a healthy group of nonobese adults. Dietary nitrate supplementation via BJ ingestion is thought to increase NO bioavailability through a serious of reactions: nitrate () is reduced to nitrite () by commensal bacteria in the oral cavity; nitrite is then converted to NO through interaction with a variety of substances in the gut and systemic circulation, including deoxygenated hemoglobin, xanthine oxidase, polyphenols, and ascorbic acid [25, 26]. The reduction of nitrate to nitrite can be inhibited with prior use of antibacterial mouthwash [23, 27–29], thus abrogating the NO-mediated beneficial effects of BJ consumption and serving as an experiment control. Accordingly, we hypothesized, in obese adults, oral glucose tolerance would be superior following coingestion of BJ plus glucose (BJ + Gluc) without prior use of antibacterial mouthwash, compared with ingestion of BJ + Gluc following prior mouthwash use. Additionally, we hypothesized that use of mouthwash would not influence oral glucose tolerance in nonobese adults following BJ + Gluc ingestion. As an additional experimental control, to determine the independent effects of mouthwash on glucose tolerance, water plus glucose was ingested with and without prior mouthwash use.
2.1. Research Participants
Adult members of the university campus and local community were invited to participate in the study. Inclusion criteria included the following: age within the range 18–70 years, sedentary lifestyle (≤20 min/day of exercise, ≤2 days/week), and weight stability (±2 kg) during the previous 6 months. Exclusion criteria included the following: current or past use (previous 2 years) of tobacco products, pregnancy or nursing, use of vitamins, supplements or medications known to influence glucose tolerance, history of diabetes, and concurrent participation in another study. Routine use of mouthwash was not an exclusion criterion. Participants were classified as obese when their body mass index (BMI) was ≥30 kg/m2. The Institutional Review Board at Colorado State University approved the experimental protocol. The nature, purpose, and risks of the study were explained to each research participant before written informed consent was obtained.
2.2. Experimental Design
Two modified oral glucose tolerance tests were administered, on two separate occasions, in a random order, separated by a minimum of 7 and a maximum of 28 days (dictated by research participant availability). A schematic of the events is presented in Figure 1. Participants reported to the laboratory early in the morning following 12-hour fast and 24-hour abstention from vigorous physical activity. In addition, participants were informed as to the types of foods known to be rich in nitrates, such as leafy green vegetables, beets, and cured meats and instructed to abstain from these foods during the 24 hours prior to each laboratory visit. No additional attempt was made to control, record, or reproduce eating behavior. To prevent inadvertent removal of commensal bacteria in the oral cavity, participants also abstained from teeth cleaning, flossing, and use of mouthwash during the 18 hours prior to each test. Within five minutes, participants ingested 500 mL of BJ (Biotta, Carmel, Indiana, USA), estimated to contain approximately 17 mmol of nitrate and supplemented with 25 g of glucose (total carbohydrate load: 75 g), with and without a prior antibacterial mouthwash procedure: one 60 s rinse with 10 mL of 1.5% H2O2 (Peroxyl; Colgate Oral Pharmaceuticals, Inc., New York, NY) followed by two 60 s rinses with 10 mL of antibacterial mouthwash (chlorhexidine digluconate; Corsodyl, BCM Ltd., Nottingham, UK). Venous blood (~3 mL) was sampled immediately prior to BJ + Gluc ingestion and again after 5, 10, 20, 30, 45, 60, 90, and 120 minutes and analyzed immediately for concentrations of glucose (automated device: 2300 Stat Plus, Yellow Springs Instruments, Yellow Springs, Ohio). Venous blood (~7 mL) was also sampled immediately prior to BJ + Gluc ingestion and again after 10, 20, 30, and 120 minutes and analyzed for insulin concentrations (enzyme-linked immunosorbent assay, ALPCO Diagnostics, Salem, NH). Insulin sensitivity was estimated via the Matsuda Index . If insulin sensitivity was greater without prior mouthwash, one possible explanation was that mouthwash blunted glucose tolerance. To explore this potential confounding issue, during two additional/separate visits, a subset of participants who completed the BJ experiments ingested water, supplemented with 75 g of glucose, with and without prior mouthwash use.
2.3. Statistical Analysis
Analysis of variance (ANOVA), with repeated measures when appropriate, was used to compare insulin sensitivity and circulating glucose and insulin concentrations in nonobese and obese adults. To determine the independent effects of mouthwash on glucose tolerance, ANOVA was also used to compare circulating glucose and insulin concentrations and insulin sensitivity. Multiple comparisons of factor means were performed using Newman-Keuls test. The level of statistical significance was set at . Data are reported as mean ± SE.
12 nonobese (6 males and 6 females; BMI: kg/m2; age: years) and 10 obese adults (2 males and 8 females; BMI: kg/m2, age: years) were tested. Blood glucose and plasma insulin concentrations, together with insulin sensitivity, are displayed in Figure 2. Blood glucose concentration after BJ + Gluc consumption was greater in obese compared with nonobese adults at 60 and 90 minutes (). Inhibition of oral bacteria nitrate reductase activity with mouthwash did not influence glucose or insulin in either group (). Insulin sensitivity, as represented by the Matsuda Index (where a higher value reflects a greater insulin sensitivity), was lower in obese compared with nonobese adults (). Antibacterial mouthwash rinsing decreased insulin sensitivity in obese but not in nonobese adults (). Although the current study was not designed with the intention of making meaningful sex comparisons, three-way analysis of variance of the Matsuda Index data revealed no main effect of sex () and no interaction between sex and obesity status (), sex and beet juice with/without mouthwash (), and sex, obesity status, and beet juice with/without mouthwash ().
In a subset comprising both nonobese () and obese () adults (2 males and 7 females; BMI: kg/m2; age: years), mouthwash did not affect blood glucose or insulin concentrations following consumption of water and glucose (Figure 3; ); similarly, insulin sensitivity was unaffected (). Visual inspection did not reveal any obvious obesity-mediated differences within the water/mouthwash data.
The novel findings of this study were the following: (1) insulin sensitivity was improved in obese but not in nonobese adults following ingestion of BJ + Gluc when oral bacteria nitrate reduction was not inhibited and (2) inhibition of oral bacteria nitrate reduction prior to ingestion of water plus glucose did not affect insulin sensitivity. The implication is obese adults at risk of developing insulin resistance may benefit from ingestion of healthy nitrate-rich foods during meals.
The current study is not the first to investigate the influence of dietary nitrate on glucose regulation in adult humans [18–23, 31]. Using a variety of techniques, including the hyperinsulinemic euglycemic clamp and the oral glucose tolerance test, none of the previous studies report a favorable effect of either acute or short-term (2 weeks) dietary nitrate glucose regulation [18–23]. One critical and discriminatory difference between these studies and the present study pertains to the timing of nitrate ingestion. Many of the techniques for assessing glucose regulation require that the research participant be in a fasted state, making acute delivery of dietary nitrate problematic. Accordingly, in most of the prior studies, nitrate ingestion occurred between 2.5 and 12 hours prior to assessment of glucose control; however in the present study the nitrate ingestion (as beet juice) occurred concurrently with assessment, that is, the BJ composed part of the carbohydrate challenge. Thus, the inference may be that, for maximum benefit to glucose control, obese adults should include dietary nitrate(s) (e.g., beets and leafy green vegetables) as part of their meal.
Dietary nitrate, in the absence of antibacterial mouthwash use, improved insulin sensitivity during a glucose challenge in obese but not in nonobese adults. This observation is consistent with prior reports of lower NO bioavailability in obese compared with nonobese adults [3, 24], increased NO bioavailability following BJ ingestion [25, 26], and improved insulin sensitivity following stimulation of NO generating pathways and/or dietary nitrate administration in animal models [15, 16]. Lower NO bioavailability in obese adults may be attributed to one or more factors, including increased oxidative stress [32, 33], chronic inflammation [34, 35], and/or limited availability of NO substrates such as tetrahydrobiopterin (BH4), citrulline, and/or L-arginine [3, 24, 36]. In turn, the lower NO bioavailability of obese adults may contribute to impaired glucose regulation on account of the important role of NO in pancreatic beta-cell function  and insulin dependent and independent mechanisms of glucose clearance [38, 39]. Accordingly, the potential for favorable outcomes for glucose regulation in obese adults during increased NO bioavailability, mediated by dietary nitrate ingestion, is intuitively appealing.
There are several experimental considerations worthy of discussion. For example, as described within Methods, aside from instructions to abstain from high nitrate foodstuffs prior to glucose tolerance assessment, no attempt was made to control, record, or reproduce eating behavior. While it is possible that this lack of control may have somehow biased our data and influenced our final interpretation, we feel that this is unlikely on account of the following: (1) the order of oral glucose tolerance tests with/without mouthwash was randomized and (2) there is no reason to suspect that nonobese subjects would change their eating behavior midway through the study in a manner that was different to how the obese subjects might change their behavior.
In the context of an exploratory study, we believe our data are sufficiently provocative to provide impetus for further investigation. The rigor of subsequent studies could be improved through a variety of modifications, including the addition of quantification of NO, circulating concentrations of nitrate and nitrite, and nitrate reductase activity of commensal bacteria. Inclusion of these measurements would confirm the influence of antibacterial mouthwash on the inhibition of nitrite and NO production from nitrate. Further, insight into basal differences between obese and nonobese adults pertaining to NO bioavailability and concentrations of nitrate and nitrite would also be provided. An additional consideration is the use of nitrate-free BJ, as previously described . This would alleviate the need for the complicated mouthwash procedure utilized in the current study and also make the additional studies of sweetened water with and without mouthwash redundant. In the current study, the estimated nitrate content of the 500 mL of BJ was 17 mmol. Relative to previous studies, this represents a large volume of BJ and a high nitrate load and may account for some of the reported differences pertinent to glucose control [18–22]. It might be of value for follow-up studies to explore the potential of a dose-response relationship and begin to identify an optimum nitrate dose. Further, as an alternative to BJ, nitrate-rich fruits and vegetables (e.g., spinach and celery) could also be studied. Finally, from a public health perspective, we infer that obese adults at risk of developing insulin resistance may benefit from ingestion of healthy nitrate-rich foods during meals. In the current study BJ was coingested with glucose only. To support/refute our inference, follow-up studies could examine the influence of BJ coingestion with an actual, mixed-substrate meal.
In summary, we are the first to demonstrate that the metabolic response to beet juice combined with glucose is more favorable in obese adults when nitrate reductase activity is not inhibited. The inference is that beet juice ingestion augmented NO bioavailability and promoted insulin sensitivity. The implication for public health is postprandial glucose control in obese adults may be improved if dietary nitrate(s) are included as part of their meal.
Preliminary data from the study described in the current manuscript were presented in a free communication at the 14th International Sport Sciences Congress, Antalya, Turkey, in November 2016; an abstract of the study was published to support this presentation.
The authors declare that there is no conflict of interests regarding the publication of this paper.
- B. E. Sansbury and B. G. Hill, “Regulation of obesity and insulin resistance by nitric oxide,” Free Radical Biology and Medicine, vol. 73, pp. 383–399, 2014.
- A. Jankovic, A. Korac, B. Buzadzic et al., “Targeting the NO/superoxide ratio in adipose tissue: relevance to obesity and diabetes management,” British Journal of Pharmacology, 2016.
- H.-J. Gruber, C. Mayer, H. Mangge, G. Fauler, N. Grandits, and M. Wilders-Truschnig, “Obesity reduces the bioavailability of nitric oxide in juveniles,” International Journal of Obesity, vol. 32, no. 5, pp. 826–831, 2008.
- W. S. Jobgen, S. K. Fried, W. J. Fu, C. J. Meininger, and G. Wu, “Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates,” Journal of Nutritional Biochemistry, vol. 17, no. 9, pp. 571–588, 2006.
- Z. Dai, Z. Wu, Y. Yang et al., “Nitric oxide and energy metabolism in mammals,” BioFactors, vol. 39, no. 4, pp. 383–391, 2013.
- S. Cook, O. Hugli, M. Egli et al., “Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice,” Swiss Medical Weekly, vol. 133, no. 25-26, pp. 360–363, 2003.
- E. A. Bradley, S. M. Richards, M. A. Keske, and S. Rattigan, “Local NOS inhibition impairs vascular and metabolic actions of insulin in rat hindleg muscle in vivo,” American Journal of Physiology—Endocrinology and Metabolism, vol. 305, no. 6, pp. E745–E750, 2013.
- E. Galluccio, P. Piatti, L. Citterio et al., “Hyperinsulinemia and impaired leptin-adiponectin ratio associate with endothelial nitric oxide synthase polymorphisms in subjects with in-stent restenosis,” American Journal of Physiology—Endocrinology and Metabolism, vol. 294, no. 5, pp. E978–E986, 2008.
- L. D. Monti, C. Barlassina, L. Citterio et al., “Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome,” Diabetes, vol. 52, no. 5, pp. 1270–1275, 2003.
- S. J. Bailey, P. Winyard, A. Vanhatalo et al., “Dietary nitrate supplementation reduces the O2 cost of low-intensity exercise and enhances tolerance to high-intensity exercise in humans,” Journal of Applied Physiology, vol. 107, no. 4, pp. 1144–1155, 2009.
- K. E. Lansley, P. G. Winyard, S. J. Bailey et al., “Acute dietary nitrate supplementation improves cycling time trial performance,” Medicine and Science in Sports and Exercise, vol. 43, no. 6, pp. 1125–1131, 2011.
- B. C. Breese, M. A. Mcnarry, S. Marwood, J. R. Blackwell, S. J. Bailey, and A. M. Jones, “Beetroot juice supplementation speeds O2 uptake kinetics and improves exercise tolerance during severe-intensity exercise initiated from an elevated metabolic rate,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 305, no. 12, pp. R1441–R1450, 2013.
- P. J. Joris and R. P. Mensink, “Beetroot juice improves in overweight and slightly obese men postprandial endothelial function after consumption of a mixed meal,” Atherosclerosis, vol. 231, no. 1, pp. 78–83, 2013.
- E. L. Levitt, J. T. Keen, and B. J. Wong, “Augmented reflex cutaneous vasodilatation following short-term dietary nitrate supplementation in humans,” Experimental Physiology, vol. 100, no. 6, pp. 708–718, 2015.
- H. Jiang, A. C. Torregrossa, A. Potts et al., “Dietary nitrite improves insulin signaling through GLUT4 translocation,” Free Radical Biology and Medicine, vol. 67, pp. 51–57, 2014.
- S. Khalifi, A. Rahimipour, S. Jeddi, M. Ghanbari, F. Kazerouni, and A. Ghasemi, “Dietary nitrate improves glucose tolerance and lipid profile in an animal model of hyperglycemia,” Nitric Oxide, vol. 44, pp. 24–30, 2015.
- M. Carlström, F. J. Larsen, T. Nyström et al., “Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 41, pp. 17716–17720, 2010.
- Z. Bahadoran, A. Ghasemi, P. Mirmiran, F. Azizi, and F. Hadaegh, “Beneficial effects of inorganic nitrate/nitrite in type 2 diabetes and its complications,” Nutrition and Metabolism, vol. 12, article 16, 2015.
- N. M. Cermak, D. Hansen, I. W. K. Kouw et al., “A single dose of sodium nitrate does not improve oral glucose tolerance in patients with type 2 diabetes mellitus,” Nutrition Research, vol. 35, no. 8, pp. 674–680, 2015.
- F. J. Larsen, T. A. Schiffer, B. Ekblom et al., “Dietary nitrate reduces resting metabolic rate: a randomized, crossover study in humans,” American Journal of Clinical Nutrition, vol. 99, no. 4, pp. 843–850, 2014.
- M. Gilchrist, P. G. Winyard, K. Aizawa, C. Anning, A. Shore, and N. Benjamin, “Effect of dietary nitrate on blood pressure, endothelial function, and insulin sensitivity in type 2 diabetes,” Free Radical Biology and Medicine, vol. 60, pp. 89–97, 2013.
- A. W. Ashor, S. Chowdhury, C. Oggioni et al., “Inorganic nitrate supplementation in young and old obese adults does not affect acute glucose and insulin responses but lowers oxidative stress,” The Journal of Nutrition, vol. 146, no. 11, pp. 2224–2232, 2016.
- S. Betteridge, R. Bescós, M. Martorell et al., “No effect of acute beetroot juice ingestion on oxygen consumption, glucose kinetics, or skeletal muscle metabolism during submaximal exercise in males,” Journal of Applied Physiology, vol. 120, no. 4, pp. 391–398, 2016.
- I. L. Williams, S. Wheatcroft, A. M. Shah, and M. T. Kearney, “Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans,” International Journal of Obesity, vol. 26, no. 6, pp. 754–764, 2002.
- J. O. Lundberg, M. Carlström, F. J. Larsen, and E. Weitzberg, “Roles of dietary inorganic nitrate in cardiovascular health and disease,” Cardiovascular Research, vol. 89, no. 3, pp. 525–532, 2011.
- S. Lidder and A. J. Webb, “Vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate-nitrite-nitric oxide pathway,” British Journal of Clinical Pharmacology, vol. 75, no. 3, pp. 677–696, 2013.
- M. Govoni, E. Å. Jansson, E. Weitzberg, and J. O. Lundberg, “The increase in plasma nitrite after a dietary nitrate load is markedly attenuated by an antibacterial mouthwash,” Nitric Oxide, vol. 19, no. 4, pp. 333–337, 2008.
- C. P. Bondonno, A. H. Liu, K. D. Croft et al., “Antibacterial mouthwash blunts oral nitrate reduction and increases blood pressure in treated hypertensive men and women,” American Journal of Hypertension, vol. 28, no. 5, pp. 572–575, 2015.
- S. T. J. Mcdonagh, L. J. Wylie, P. G. Winyard, A. Vanhatalo, and A. M. Jones, “The effects of chronic nitrate supplementation and the use of strong and weak antibacterial agents on plasma nitrite concentration and exercise blood pressure,” International Journal of Sports Medicine, vol. 36, no. 14, pp. 1177–1185, 2015.
- M. Matsuda and R. A. DeFronzo, “Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp,” Diabetes Care, vol. 22, no. 9, pp. 1462–1470, 1999.
- P. C. Wootton-Beard, K. Brandt, D. Fell, S. Warner, and L. Ryan, “Effects of a beetroot juice with high neobetanin content on the early-phase insulin response in healthy volunteers,” Journal of Nutritional Science, vol. 3, article e9, 2014.
- G. Hulsegge, G.-C. M. Herber-Gast, A. M. W. Spijkerman et al., “Obesity and age-related changes in markers of oxidative stress and inflammation across four generations,” Obesity, vol. 24, no. 6, pp. 1389–1396, 2016.
- J. F. Keaney Jr., M. G. Larson, R. S. Vasan et al., “Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 3, pp. 434–439, 2003.
- A. Virdis, “Endothelial dysfunction in obesity: role of inflammation,” High Blood Pressure and Cardiovascular Prevention, vol. 23, no. 2, pp. 83–85, 2016.
- R. Aghamohammadzadeh, R. D. Unwin, A. S. Greenstein, and A. M. Heagerty, “Effects of obesity on perivascular adipose tissue vasorelaxant function: nitric oxide, inflammation and elevated systemic blood pressure,” Journal of Vascular Research, vol. 52, no. 5, pp. 299–305, 2015.
- G. Wu and C. J. Meininger, “Nitric oxide and vascular insulin resistance,” BioFactors, vol. 35, no. 1, pp. 21–27, 2009.
- T. Sunouchi, K. Suzuki, K. Nakayama, and T. Ishikawa, “Dual effect of nitric oxide on ATP-sensitive K+ channels in rat pancreatic β cells,” Pflugers Archiv European Journal of Physiology, vol. 456, no. 3, pp. 573–579, 2008.
- C. K. Roberts, R. J. Barnard, S. H. Scheck, and T. W. Balon, “Exercise-stimulated glucose transport in skeletal muscle is nitric oxide dependent,” American Journal of Physiology—Endocrinology and Metabolism, vol. 273, no. 1, part 1, pp. E220–E225, 1997.
- D. Roy, M. Perreault, and A. Marette, “Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent,” American Journal of Physiology—Endocrinology & Metabolism, vol. 274, no. 4, part 1, pp. E692–E699, 1998.
- K. E. Lansley, P. G. Winyard, J. Fulford et al., “Dietary nitrate supplementation reduces the O2 cost of walking and running: a placebo-controlled study,” Journal of Applied Physiology, vol. 110, no. 3, pp. 591–600, 2011.
Copyright © 2017 Joseph W. Beals et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.